Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium.

Ishii W, Liepnieks JJ, Yamada T, Benson MD, Kluve-Beckerman B.

Amyloid. 2013 Jun;20(2):61-71. doi: 10.3109/13506129.2013.775941. Epub 2013 Mar 6.

PMID:
23461622
2.

Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties.

Takase H, Tanaka M, Miyagawa S, Yamada T, Mukai T.

Biochem Biophys Res Commun. 2014 Jan 31;444(1):92-7. doi: 10.1016/j.bbrc.2014.01.029. Epub 2014 Jan 16.

PMID:
24440699
3.

Protein profiling of isolated uterine AA amyloidosis causing fetal death in goats.

Gaffney PM, Barr B, Rowe JD, Bett C, Drygiannakis I, Giannitti F, Trejo M, Ghassemian M, Martin P, Masliah E, Sigurdson CJ.

FASEB J. 2015 Mar;29(3):911-9. doi: 10.1096/fj.14-256081. Epub 2014 Nov 24.

4.

Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation.

Meek RL, Hoffman JS, Benditt EP.

J Exp Med. 1986 Mar 1;163(3):499-510.

5.

Amyloid formation in the rat: adenoviral expression of mouse serum amyloid A proteins.

Yu J, Guo JT, Zhu H, Kindy MS.

Amyloid. 2000 Mar;7(1):32-40.

PMID:
10842703
6.
8.

Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model.

Magy N, Benson MD, Liepnieks JJ, Kluve-Beckerman B.

Amyloid. 2007 Mar;14(1):51-63.

PMID:
17453625
9.

Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.

Liepnieks JJ, Kluve-Beckerman B, Benson MD.

Biochim Biophys Acta. 1995 Jan 25;1270(1):81-6.

PMID:
7827140
10.
11.

Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.

Liu Y, Cui D, Hoshii Y, Kawano H, Une Y, Gondo T, Ishihara T.

Scand J Immunol. 2007 Nov;66(5):495-500.

12.

Cathepsin D activity protects against development of type AA amyloid fibrils.

van der Hilst JC, Kluve-Beckerman B, van der Meer JW, Simon A.

Eur J Clin Invest. 2009 May;39(5):412-6. doi: 10.1111/j.1365-2362.2009.02104.x.

PMID:
19740371
13.

Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis.

Guo JT, Yu J, Grass D, de Beer FC, Kindy MS.

J Neurosci. 2002 Jul 15;22(14):5900-9.

15.

Metabolism of amyloid proteins.

Benson MD, Kluve-Beckerman B, Liepnieks JJ, Murrell JR, Hanes D, Uemichi T.

Ciba Found Symp. 1996;199:104-13; discussion 113-8.

PMID:
8915606
16.

Expression of mouse apolipoprotein SAA1.1 in CE/J mice: isoform-specific effects on amyloidogenesis.

Yu J, Zhu H, Guo JT, de Beer FC, Kindy MS.

Lab Invest. 2000 Dec;80(12):1797-806.

PMID:
11140693
17.

Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis.

van der Hilst JC, Yamada T, Op den Camp HJ, van der Meer JW, Drenth JP, Simon A.

Rheumatology (Oxford). 2008 Nov;47(11):1651-4. doi: 10.1093/rheumatology/ken371. Epub 2008 Sep 24.

18.

Differential affinity of serum amyloid A1 isotypes for high-density lipoprotein.

Yamada T, Sato J, Okuda Y.

Amyloid. 2009 Dec;16(4):196-200. doi: 10.3109/13506120903421546.

PMID:
19922330
19.

Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome.

van der Hilst JC, Drenth JP, Bodar EJ, Bijzet J, van der Meer JW, Simon A; International HIDS Study Group.

Amyloid. 2005 Jun;12(2):115-9.

PMID:
16011988
20.

Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.

Srinivasan S, Patke S, Wang Y, Ye Z, Litt J, Srivastava SK, Lopez MM, Kurouski D, Lednev IK, Kane RS, Colón W.

J Biol Chem. 2013 Jan 25;288(4):2744-55. doi: 10.1074/jbc.M112.394155. Epub 2012 Dec 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk